Pay in 4 interest-free payments of $5.54 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
ConjuChem Biotechnologies originally developed CJC-1295 for potential treatment of lipodystrophy and growth hormone deficiency
When in doubt both agents can be offered within the same clinic, with product selection determined at consultation based on the individual patient profile
Consulting a healthcare professional to understand the potential risks and benefits is essential
J Clin Med 2023
The first part is GHK, a tripeptide containing the amino acid sequence glycyl-histidyl-lysine
US$ 22.05
US$ 23.32
US$ 23.26
US$ 23.85
US$ 21.81
US$ 23.89
